About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Transition of Chairman of Board

April 21, 2017

Click here to read more

Post navigation

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

Phosphagenics Notice of Annual General Meeting

Related Posts

Chairman Resignation

May 12, 2015

Phosphagenics Begins its Animal Health and Nutrition Program

September 28, 2015

Apppointment of Consultant to Assist in Commercialising TPM for the Mass Market

June 9, 2015

Recent Posts

Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.